Article
Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C.
Journal of clinical gastroenterology - 1 Aug 2009
Chew Kara W, Allen Scott A, Taylor Lynn E, Rich Josiah D, Feller Edward
Abstract excerpt
GOALS: To report our experience with pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) RNA-positive inmates at the Rhode Island Department of Corrections. BACKGROUND: An estimated 1 out of 3 HCV-infected individuals will spend time in a jail or prison within a 1-year period, making prisons a unique setting for management of chronic HCV. STUDY: Chart review of all inmates identified as having...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
